A Phase 2 study of cisplatin analog CI-973 in the treatment of patients with refractory, advanced ovarian cancer
dc.contributor.author | Roberts, James A. | en_US |
dc.contributor.author | Kudelka, A. P. | en_US |
dc.contributor.author | Spriggs, D. R. | en_US |
dc.contributor.author | Muggia, F. | en_US |
dc.contributor.author | Lurain, J. | en_US |
dc.contributor.author | Grove, W. | en_US |
dc.contributor.author | Kowal, C. | en_US |
dc.date.accessioned | 2010-06-01T18:22:57Z | |
dc.date.available | 2010-06-01T18:22:57Z | |
dc.date.issued | 1996-07 | en_US |
dc.identifier.citation | Roberts, J.A.; Kudelka, A.P.; Spriggs, D.R.; Muggia, F.; Lurain, J.; Grove, W.; Kowal, C. (1996). "A Phase 2 study of cisplatin analog CI-973 in the treatment of patients with refractory, advanced ovarian cancer." International Journal of Gynecological Cancer 6(4): 257-260. <http://hdl.handle.net/2027.42/71591> | en_US |
dc.identifier.issn | 1048-891X | en_US |
dc.identifier.issn | 1525-1438 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/71591 | |
dc.format.extent | 397866 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Science Inc. | en_US |
dc.rights | International Gynecologic Cancer Society | en_US |
dc.subject.other | CI-973 | en_US |
dc.subject.other | Ovarian Cancer | en_US |
dc.subject.other | Phase 2 Study | en_US |
dc.subject.other | Platinum Analog | en_US |
dc.title | A Phase 2 study of cisplatin analog CI-973 in the treatment of patients with refractory, advanced ovarian cancer | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Obstetrics and Gynecology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | * Division of Gynecologic Oncology, University of Michigan, Ann Arbor, Michigan, | en_US |
dc.contributor.affiliationum | ** Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationother | Section of Gynecologic Medical Oncology, M.D. Anderson Cancer Center, Houston, Texas, | en_US |
dc.contributor.affiliationother | Department of Human Oncology, University of Wisconsin, Madison, Wisconsin, | en_US |
dc.contributor.affiliationother | Kenneth Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, | en_US |
dc.contributor.affiliationother | Section of Gynecologic Oncology, Northwestern University Medical School, Chicago, Illinois and | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/71591/1/j.1525-1438.1996.06040257.x.pdf | |
dc.identifier.doi | 10.1046/j.1525-1438.1996.06040257.x | en_US |
dc.identifier.source | International Journal of Gynecological Cancer | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.